Neurocrine: 4Q Earnings Snapshot

·1 min read

SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Thursday reported fourth-quarter earnings of $347.9 million.

The San Diego-based company said it had net income of $3.58 per share.

The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 59 cents per share.

The biopharmaceutical company posted revenue of $247.9 million in the period, which did not meet Street forecasts. Twelve analysts surveyed by Zacks expected $260.4 million.

For the year, the company reported profit of $407.3 million, or $4.16 per share. Revenue was reported as $1.05 billion.

Neurocrine shares have risen 20% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $114.55, a rise of 11% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NBIX at